Page 59 - GPD-4-2
P. 59

Gene & Protein in Disease                                                          Orexin in depression



               doi: 10.1016/j.euroneuro.2021.05.005               the interaction with orexin 1 and cannabinoid 1 receptors in
                                                                  rats. Neuropeptides. 2019;73:25-33.
            128. Sarathi Chakraborty D, Choudhury S, Lahiry S.
               Daridorexant, a recently approved dual orexin receptor      doi: 10.1016/j.npep.2018.12.001
               antagonists (DORA) in treatment of Insomnia.  Sleep Sci.   138. Ho YC, Lee HJ, Tung LW,  et al. Activation of orexin 1
               2023;16(2):256-264.
                                                                  receptors in the periaqueductal gray of male rats leads
               doi: 10.1055/s-0043-1770805                        to antinociception via retrograde endocannabinoid
                                                                  (2-arachidonoylglycerol)-induced disinhibition. J Neurosci.
            129. Cicala G, Barbieri MA, Russo G, Salvo F, Spina E.   2011;31(41):14600-14610.
               Safety of dual orexin receptor antagonist daridorexant:
               A  disproportionality analysis  of  publicly  available  FAERS      doi: 10.1523/jneurosci.2671-11.2011
               data. Pharmaceuticals (Basel). 2024;17(3):342.  139. Cao XL, Peng XM, Li GB,  et al. Chaihu-longgu-muli
               doi: 10.3390/ph17030342                            decoction improves sleep disorders by restoring orexin-a
                                                                  function in CKD mice. Front Endocrinol. 2023;14:1206353.
            130. Cruz HG, Hay JL, Hoever P,  et al. Pharmacokinetic and
               pharmacodynamic interactions between almorexant, a      doi: 10.3389/fendo.2023.1206353
               dual orexin receptor antagonist, and desipramine.  Eur   140. Nie Y, Liang J, Sun J, Li J, Zhai X, Zhao P. Orexin A
               Neuropsychopharmacol. 2014;24(8):1257-1268.        alleviates  LPS-induced  acute  lung injury  by inhibiting
               doi: 10.1016/j.euroneuro.2014.05.002               macrophage activation through JNK-mediated autophagy.
                                                                  Int Immunopharmacol. 2023;124(Pt B):111018.
            131. Malherbe P, Borroni E, Pinard E, Wettstein JG, Knoflach
               F. Biochemical and electrophysiological characterization      doi: 10.1016/j.intimp.2023.111018
               of almorexant, a dual orexin 1 receptor (OX1)/Orexin 2   141. Hou Y, Liu Y, Liu C, et al. Xiaoyaosan regulates depression-
               receptor (OX2) antagonist: Comparison with selective OX1   related behaviors with physical symptoms by modulating
               and OX2 antagonists. Mol Pharmacol. 2009;76(3):618-31.  orexin A/OxR1 in the hypothalamus. Anat Rec (Hoboken).
               doi: 10.1124/mol.109.055152                        2020;303(8):2144-2153.
            132. Mould R, Brown J, Marshall FH, Langmead CJ. Binding      doi: 10.1002/ar.24386
               kinetics differentiates functional antagonism of orexin-2   142. Yan L, Lonstein JS, Nunez AA. Light as a modulator of
               receptor ligands. Br J Pharmacol. 2014;171(2):351-363.  emotion and cognition: Lessons learned from studying a
               doi: 10.1111/bph.12245                             diurnal rodent. Horm Behav. 2019;111:78-86.
            133. Nollet M, Leman S. Role of orexin in the pathophysiology of      doi: 10.1016/j.yhbeh.2018.09.003
               depression: Potential for pharmacological intervention. CNS   143. Schöne C, Burdakov D. Orexin/hypocretin and organizing
               Drugs. 2013;27(6):411-422.                         principles for a diversity of wake-promoting neurons in the
               doi: 10.1007/s40263-013-0064-z                     brain. Curr Top Behav Neurosci. 2017;33:51-74.
            134. Ito N, Yabe T, Gamo Y, et al. I.C.V. Administration of orexin-a      doi: 10.1007/7854_2016_45
               induces an antidepressive-like effect through hippocampal   144. Brown RE, Sergeeva O, Eriksson KS, Haas HL. Orexin A
               cell proliferation. Neuroscience. 2008;157(4):720-732.  excites serotonergic neurons in the dorsal raphe nucleus of
               doi: 10.1016/j.neuroscience.2008.09.042            the rat. Neuropharmacology. 2001;40(3):457-459.
            135. Recinella L, Chiavaroli A, Ferrante C, et al. Effects of central      doi: 10.1016/s0028-3908(00)00178-7
               RVD-hemopressin(α) administration on anxiety, feeding   145. Liu RJ, van den Pol AN, Aghajanian GK. Hypocretins
               behavior and hypothalamic neuromodulators in the rat.   (Orexins) regulate serotonin neurons in the dorsal raphe
               Pharmacol Rep. 2018;70(4):650-657.                 nucleus by excitatory direct and inhibitory indirect actions.
               doi: 10.1016/j.pharep.2018.01.010                  J Neurosci. 2002;22(21):9453-9464.
            136. Kim HJJ, Zagzoog A, Ceni C, Ferrisi R, Janz N, Laprairie      doi: 10.1523/jneurosci.22-21-09453.2002
               RB. Dual cannabinoid and orexin regulation of anhedonic   146. Dimatelis JJ, Mtintsilana A, Naidoo V, Stein DJ, Russell VA.
               behaviour caused by prolonged restraint stress.  Brain Sci.   Chronic light exposure alters serotonergic and orexinergic
               2023;13(2):314.                                    systems in the rat brain and reverses maternal separation-
                                                                  induced increase in orexin receptors in the prefrontal cortex.
               doi: 10.3390/brainsci13020314
                                                                  Metab Brain Dis. 2018;33(2):433-441.
            137. Pourrahimi AM, Abbasnejad M, Esmaeili-Mahani S,
               Kooshki R, Raoof M. Intra-periaqueductal gray matter      doi: 10.1007/s11011-017-0123-0
               administration of orexin-A exaggerates pulpitis-induced   147. James MH, Campbell EJ, Walker FR, et al. Exercise reverses
               anxiogenic responses and c-fos expression mainly through   the effects of early life stress on orexin cell reactivity in male


            Volume 4 Issue 2 (2025)                         23                              doi: 10.36922/gpd.4210
   54   55   56   57   58   59   60   61   62   63   64